BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Said A, Ghufran A. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma. World J Clin Oncol 2017; 8(6): 429-436 [PMID: 29291167 DOI: 10.5306/wjco.v8.i6.429]
URL: https://www.wjgnet.com/1948-5182/full/v8/i6/429.htm
Number Citing Articles
1
Shih‐Wei Lai. Risk factors for hepatocellular carcinomaCancer 2019; 125(3): 482 doi: 10.1002/cncr.31802
2
Anne Sophie Schou, Jonas Ellegaard Nielsen, Anders Askeland, Malene Møller Jørgensen. Advances in Clinical Chemistry 2020; 99: 1 doi: 10.1016/bs.acc.2020.02.011
3
Stephanie Chen, Samantha Chao, Monica Konerman, Wei Zhang, Huiying Rao, Elizabeth Wu, Andy Lin, Lai Wei, Anna S. Lok. Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, ChinaDigestive Diseases and Sciences 2019; 64(12): 3480 doi: 10.1007/s10620-019-05709-0
4
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical ChallengesDigestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
5
Koichi Kato, Moto Fukai, Kanako C. Hatanaka, Akira Takasawa, Tomoyuki Aoyama, Takahiro Hayasaka, Yoshihiro Matsuno, Toshiya Kamiyama, Yutaka Hatanaka, Akinobu Taketomi. Versican Secreted by Cancer-Associated Fibroblasts is a Poor Prognostic Factor in Hepatocellular CarcinomaAnnals of Surgical Oncology 2022;  doi: 10.1245/s10434-022-11862-0
6
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approachesTherapeutic Advances in Gastroenterology 2019; 12: 175628481983620 doi: 10.1177/1756284819836205
7
Takahiro Kodama, Jing Yi, Justin Y. Newberg, Jean C. Tien, Hao Wu, Milton J. Finegold, Michiko Kodama, Zhubo Wei, Takeshi Tamura, Tetsuo Takehara, Randy L. Johnson, Nancy A. Jenkins, Neal G. Copeland. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesisProceedings of the National Academy of Sciences 2018; 115(44) doi: 10.1073/pnas.1808968115
8
Talhah Zubair, Timothy Yen, Gordon Gao. Solitary Extrahepatic Intramuscular Metastasis from Cryptogenic Hepatocellular CarcinomaACG Case Reports Journal 2018; 5(1): e64 doi: 10.14309/crj.2018.64
9
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCCInternational Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
10
Chiao-Lin Hsu, Fu-Zong Wu, Kung-Hung Lin, Yu-Hsun Chen, Pin-Chieh Wu, Yan-Hua Chen, Chi-Shen Chen, Wen-Hwa Wang, Guang-Yuan Mar, Hsien-Chung Yu. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health CheckupClinical and Translational Gastroenterology 2019; 10(5): e00042 doi: 10.14309/ctg.0000000000000042
11
Han Lv, Mengyi Li, Yang Liu, Lei Zhao, Jing Sun, Di Cao, Na Zeng, Jia Liu, Yawen Liu, Shibo Bian, Peng Zhang, Zhenghan Yang, Zhongtao Zhang, Zhenchang Wang. The Clinical Value and Appropriateness Criteria of Upper Abdominal Magnetic Resonance Examinations in Patients Before and After Bariatric Surgery: a Study of 837 ImagesObesity Surgery 2020; 30(10): 3784 doi: 10.1007/s11695-020-04688-w
12
April D. Lake, Rhiannon N. Hardwick, Christopher P. Leamon, Philip S. Low, Nathan J. Cherrington. Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitisToxicology and Applied Pharmacology 2019; 368: 49 doi: 10.1016/j.taap.2019.02.009
13
Yasuyuki Shigematsu, Hiroaki Kanda, Gulanbar Amori, Yu Takahashi, Yutaka Takazawa, Kentaro Inamura. Nonalcoholic non-virus-related hepatocellular carcinoma arising from nonsteatotic liverMedicine 2022; 101(5): e28746 doi: 10.1097/MD.0000000000028746
14
Tingting Shen, Yunfei Lu, Qin Zhang. High Squalene Epoxidase in Tumors Predicts Worse Survival in Patients With Hepatocellular Carcinoma: Integrated Bioinformatic Analysis on NAFLD and HCCCancer Control 2020; 27(1): 107327482091466 doi: 10.1177/1073274820914663
15
Lijuan Liao, Deyu Duan, Yanfeng Liu, Liang Chen. LHPP inhibits hepatocellular carcinoma cell growth and metastasisCell Cycle 2020; 19(14): 1846 doi: 10.1080/15384101.2020.1783472
16
Jie Huang, Meng Li, Wen-Jun Zhoua, Ze-Min Yao, Guang Ji, Li Zhang, Ming-Zhe Zhu. Integrated miRNA and mRNA analysis identified potential mechanisms and targets of qianggan extracts in preventing nonalcoholic steatohepatitisWorld Journal of Traditional Chinese Medicine 2022; 8(1): 77 doi: 10.4103/2311-8571.335135
17
Ingo G. Steffen, Thomas Weissmann, Jan Holger Rothe, Dominik Geisel, Sascha S. Chopra, Johannes Kahn, Bernd Hamm, Timm Denecke. Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?Journal of Clinical Medicine 2020; 10(1): 98 doi: 10.3390/jcm10010098
18
Min Yao, Wenjie Zheng, Li Wang, Miao Fang, Zhizhen Dong, Dengfu Yao. Neoplasm2018;  doi: 10.5772/intechopen.77400
19
Andrea G. Izquierdo, Marcos C. Carreira, María Amil, Carlos S. Mosteiro, Tomas Garcia‐Caballero, Alfredo Fernandez‐Quintela, María P. Portillo, Felipe F. Casanueva, Ana B. Crujeiras. An energy restriction‐based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor‐promoting genesThe FASEB Journal 2020; 34(2): 2312 doi: 10.1096/fj.201901147RR
20
D. Putzer, P. Schullian, E. Braunwarth, M. Fodor, F. Primavesi, B. Cardini, T. Resch, R. Oberhuber, M. Maglione, C. Margreiter, S. Schneeberger, S. Stättner, D. Öfner-Velano, W. Jaschke, R. J. Bale. Integrating interventional oncology in the treatment of liver tumorsEuropean Surgery 2018; 50(3): 117 doi: 10.1007/s10353-018-0521-5
21
Mikyung Kim, Yunmee Rho, Rhoeun Park, Jeeyoun Jung, Geum-Sook Hwang, Youn Kyoung Seo, Ji Hae Seo, Yoonseok Heo, Tae Kyung Ha, Eunyoung Ha. Duodenal-jejunal bypass maintains hepatic S-adenosylmethionine/S-homocysteine ratio in diet-induced obese ratsSurgery for Obesity and Related Diseases 2021; 17(7): 1359 doi: 10.1016/j.soard.2021.02.011
22
Rajesh Sharma. Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018Japanese Journal of Clinical Oncology 2020; 50(12): 1370 doi: 10.1093/jjco/hyaa130
23
Jie Huang, Meng Li, Wen-Jun Zhoua, Ze-Min Yao, Guang Ji, Li Zhang, Ming-Zhe Zhu. Integrated miRNA and mRNA analysis identified potential mechanisms and targets of qianggan extracts in preventing nonalcoholic steatohepatitisWorld Journal of Traditional Chinese Medicine 2022; 8(1): 77 doi: 10.4103/wjtcm.wjtcm_48_21
24
Imaad Said, Hassan Ahad, Adnan Said. Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeuticsWorld Journal of Gastrointestinal Oncology 2022; 14(5): 947-958 doi: 10.4251/wjgo.v14.i5.947
25
Ahmed Lasfar. Liver Cancer2018;  doi: 10.5772/intechopen.81720
26
Yanan Zhang, Chunguang Wang, Hongqin Xu, Peng Xiao, Yanhang Gao. Hepatocellular carcinoma in the noncirrhotic liver: a literature reviewEuropean Journal of Gastroenterology & Hepatology 2019; 31(7): 743 doi: 10.1097/MEG.0000000000001419
27
Bronwen Williams, Nurun Tania, Lynsey Corless. Non-alcoholic fatty liver disease (NAFLD): survey of awareness and understanding among professionals in secondary careGastrointestinal Nursing 2019; 17(Sup6): S22 doi: 10.12968/gasn.2019.17.Sup6.S22
28
Hui Xia, Chun Liu, Cheng-Chung Li, Maobin Fu, Shingo Takahashi, Kang-Quan Hu, Koichi Aizawa, Suganuma Hiroyuki, Guojun Wu, Liping Zhao, Xiang-Dong Wang. Dietary Tomato Powder Inhibits High-Fat Diet–Promoted Hepatocellular Carcinoma with Alteration of Gut Microbiota in Mice Lacking Carotenoid Cleavage EnzymesCancer Prevention Research 2018; 11(12): 797 doi: 10.1158/1940-6207.CAPR-18-0188
29
Serdar A. Gurses, Sunil Banskar, Cody Stewart, Bill Trimoski, Roman Dziarski, Dipika Gupta. Nod2 protects mice from inflammation and obesity-dependent liver cancerScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77463-7
30
Zhaoming Liu, Zhen Li, Binghui Xu, Hao Yao, Shuangyu Qi, Jianxiong Tai. <p>Long Noncoding RNA PRR34-AS1 Aggravates the Progression of Hepatocellular Carcinoma by Adsorbing microRNA-498 and Thereby Upregulating FOXO3</p>Cancer Management and Research 2020; : 10749 doi: 10.2147/CMAR.S263619
31
Ozlem Kutlu, Humeyra Nur Kaleli, Ebru Ozer. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular CarcinomaCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/8543763
32
Shivani Krishnamurthy, David Gilot, Seong Beom Ahn, Vincent Lam, Joo-Shik Shin, Gilles Jackie Guillemin, Benjamin Heng. Involvement of Kynurenine Pathway in Hepatocellular CarcinomaCancers 2021; 13(20): 5180 doi: 10.3390/cancers13205180
33
Ramesh Kumar, Rajeev Nayan Priyadarshi, Utpal Anand. Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and AssociationsJournal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00051
34
Lei Cao, Hongwei Cheng, Qiuxia Jiang, Hui Li, Zhixian Wu. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinomaAging 2020; 12(5): 4573 doi: 10.18632/aging.102913
35
Noor Atika Azit, Shahnorbanun Sahran, Leow Voon Meng, Manisekar Subramaniam, Suryati Mokhtar, Azmawati Mohammed Nawi, Yun-Wen Zheng. Risk factors of hepatocellular carcinoma in type 2 diabetes patients: A two-centre study in a developing countryPLOS ONE 2021; 16(12): e0260675 doi: 10.1371/journal.pone.0260675
36
Jeongeun Hyun, Muthana Al Abo, Rajesh Kumar Dutta, Seh Hoon Oh, Kun Xiang, Xiyou Zhou, Raquel Maeso-Díaz, Rebecca Caffrey, Arun J. Sanyal, Jennifer A. Freedman, Steven R. Patierno, Cynthia A. Moylan, Manal F. Abdelmalek, Anna Mae Diehl. Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver diseaseJournal of Hepatology 2021; 75(3): 623 doi: 10.1016/j.jhep.2021.04.033
37
Geru Tao, Guangjie Zhang, Wei Chen, Chao Yang, Yazhuo Xue, Guohua Song, Shucun Qin. A randomized, placebo‐controlled clinical trial of hydrogen/oxygen inhalation for non‐alcoholic fatty liver diseaseJournal of Cellular and Molecular Medicine 2022;  doi: 10.1111/jcmm.17456
38
Lu Huang, Wei Ding, Ming-Qiang Wang, Zheng-Gen Wang, Hong-Hui Chen, Wen Chen, Qiong Yang, Ting-Na Lu, Qing Yang, Ji-Man He. Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4Journal of International Medical Research 2019; 47(10): 5239 doi: 10.1177/0300060519859750
39
Ebbe Billmann Thorgersen, Andreas Barratt‐Due, Håkon Haugaa, Morten Harboe, Søren Erik Pischke, Per H. Nilsson, Tom Eirik Mollnes. The Role of Complement in Liver Injury, Regeneration, and TransplantationHepatology 2019; 70(2): 725 doi: 10.1002/hep.30508
40
Timothy M.E. Davis, Kirsten E. Peters, S. A. Paul Chubb, Leon A. Adams, Gary P. Jeffrey, Wendy A. Davis. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes StudyJournal of Clinical Medicine 2020; 9(11): 3409 doi: 10.3390/jcm9113409
41
Hyun Jin Song, Xinyi Jiang, Linda Henry, Mindie H. Nguyen, Haesuk Park. Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysisEuropean Journal of Clinical Pharmacology 2020; 76(6): 851 doi: 10.1007/s00228-020-02854-8
42
Xiaoyu Liu, Wenhui Ju, Chuanhong Huo, Shuhong Zhang, Xingang Wang, Kai Huang. Overweight and Obesity as Independent Factors for Increased Risk of Hepatocellular Cancer-Related Mortality: A Meta-AnalysisJournal of the American College of Nutrition 2021; 40(3): 287 doi: 10.1080/07315724.2020.1751007
43
Zobair M. Younossi, Linda Henry. Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinomaJHEP Reports 2021; 3(4): 100305 doi: 10.1016/j.jhepr.2021.100305
44
Mélissa Léveillé, Jennifer L. Estall. Mitochondrial Dysfunction in the Transition from NASH to HCCMetabolites 2019; 9(10): 233 doi: 10.3390/metabo9100233
45
Claudia Isabel García-Berumen, Omar Ortiz-Avila, Manuel Alejandro Vargas-Vargas, Bricia A. del Rosario-Tamayo, Clotilde Guajardo-López, Alfredo Saavedra-Molina, Alain Raimundo Rodríguez-Orozco, Christian Cortés-Rojo. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondriaLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1024-5
46
Rodrigo Valenzuela, Macarena Ortiz, María Catalina Hernández-Rodas, Francisca Echeverría, Luis Alberto Videla. Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver DiseaseCurrent Medicinal Chemistry 2020; 27(31): 5250 doi: 10.2174/0929867326666190410121716
47
Songsong Wu, Sheng Chen, Ning Lin, Jianchuan Yang. Long non‐coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β‐catenin signalling pathway by targeting miR‐320a Journal of Cellular and Molecular Medicine 2020; 24(5): 3108 doi: 10.1111/jcmm.14977
48
Victor de Avila, James M. Paik, Leyla de Avila, Linda Henry, Denise Mohess, Alva Roche-Green, Zobair M. Younossi. Hospice care utilisation among elderly patients who died with hepatocellular carcinoma in the United StatesJHEP Reports 2021; 3(2): 100236 doi: 10.1016/j.jhepr.2021.100236
49
Flavio A. Cadegiani. Dietary Interventions in Liver Disease2019; : 39 doi: 10.1016/B978-0-12-814466-4.00004-5
50
V. V. Pavan Kedar Mukthinuthalapati, Vikash Sewram, Ntokozo Ndlovu, Stephen Kimani, Ashraf Omar Abdelaziz, Elizabeth Yu Chiao, Ghassan K. Abou-Alfa. Hepatocellular Carcinoma in Sub-Saharan AfricaJCO Global Oncology 2021; (7): 756 doi: 10.1200/GO.20.00425
51
Mami Takahashi, Mika Hori, Rikako Ishigamori, Michihiro Mutoh, Toshio Imai, Hitoshi Nakagama. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humansCancer Science 2018; 109(10): 3013 doi: 10.1111/cas.13766
52
Jessica H. Hill, Claudia Solt, Michelle T. Foster. Obesity associated disease risk: the role of inherent differences and location of adipose depotsHormone Molecular Biology and Clinical Investigation 2018; 33(2) doi: 10.1515/hmbci-2018-0012
53
Monika Pazgan-Simon, Michał Kukla, Jolanta Zuwała-Jagiełło, Aleksandra Derra, Martyna Bator, Tomasz Menżyk, Andrzej Lekstan, Ewa Grzebyk, Krzysztof Simon, Matias A. Avila. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC)PLOS ONE 2020; 15(1): e0227459 doi: 10.1371/journal.pone.0227459
54
Meng Zhang, Yuan Yuan, Qing Wang, Xiaobo Li, Jiuzhang Men, Mingxin Lin. The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKαBioscience Reports 2018; 38(6) doi: 10.1042/BSR20180644
55
Joe L. Rowles, Aiguo Han, Rita J. Miller, Jamie R. Kelly, Catherine C. Applegate, Matthew A. Wallig, William D. O’Brien, John W. Erdman. Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL/6J mice: monitored by a novel quantitative ultrasound (QUS) methodNutrition Research 2019; 63: 95 doi: 10.1016/j.nutres.2018.12.003
56
Nermin Raafat, Tarik I. Zaher, Rasha L. Etewa, Khaled M. El-gerby, Noha A. Rezk. Heat shock protein-27 and MiR-17-5p are novel diagnostic and prognostic biomarkers for hepatocellular carcinoma in Egyptian patientsGene Reports 2020; 21: 100822 doi: 10.1016/j.genrep.2020.100822
57
Yu-Shan Lee, Lee-Ching Hwang, Hsin-Yin Hsu, Meng-Ting Tsou. The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in TaiwanDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1473 doi: 10.2147/DMSO.S302207
58
Margarita N. German, Megan K. Lutz, Perry J. Pickhardt, Richard J. Bruce, Adnan Said. Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver DiseaseJournal of Clinical Gastroenterology 2020; 54(8): 733 doi: 10.1097/MCG.0000000000001260
59
Tomoki Abe, Daisaku Yamada, Kei Asukai, Shinichiro Hasegawa, Akira Tomokuni, Hiroshi Wada, Wataru Fujii, Kenji Ikezawa, Nobuyasu Fukutake, Kazuyoshi Ohkawa, Naoki Shinno, Hisashi Hara, Yoshitomo Yanagimoto, Yusuke Takahashi, Keijiro Sugimura, Kazuyoshi Yamamoto, Hajime Ushigome, Naotsugu Haraguchi, Junichi Nishimura, Masayoshi Yasui, Takeshi Omori, Hiroshi Miyata, Masayuki Ohue, Masahiko Yano, Masato Sakon, Hidenori Takahashi. Decreased CT-number in the pancreatic parenchyma is a reliable imaging biomarker of the presence of malignancies in patients with high-risk intraductal papillary mucinous neoplasmPancreatology 2020; 20(3): 442 doi: 10.1016/j.pan.2020.02.014